In the Media

"As we become ever more dependent on external sources of memory -- using GPS to guide our driving, smartphones to keep our schedules -- it's time to rethink our ideas about what 'memory' actually is."

"Researchers have a goal so ambitious it is almost unthinkable – learning how all 85bn neurons in the human brain are wired up."

"Like the the Financial Times which has totally left the Apps platform for an enhance HTML mobile Web scenario, MIT's Technology Review has abandoned its App strategy."

"President Obama and others are demanding that we raise taxes on the "rich," and two recent academic papers that have gotten a lot of attention claim to show that there will be no ill effects if we do."

"Yes, robots are becoming real-world brain scientists."

"The best work I have seen on the subject is by Nancy Leveson, professor of aeronautics and astronautics and engineering systems at MIT."

"Should Harvard and M.I.T. offer credit for these courses and even allow students to obtain their degrees online?"

"It’s not easy, after all, to experiment on a health care system."

"People have told MIT’s dean of admissions, Stuart Schmill, that he reminds them of political satirist Stephen Colbert."

"Researchers at Massachusetts Institute of Technology studied the antiviral action of mucus and, in particular, the mucin molecules - long, threadlike proteins that are the main building blocks of mucus."

"After a financial train wreck, it’s time to begin to learn lessons from the disaster and prevent its recurrence."

"The intersection of science and art is technology."

"Sometimes, an admissions officer’s job is more than sifting through enormous stacks of applications. Sometimes, an admissions officer has to take a stand."

"Professor Zittrain gave a keynote talk on Friday before a packed lecture hall at the Massachusetts Institute of Technology in Cambridge as part of ROFLCon, a two-day conference that aims to dissect and discuss the culture of the Web."

"Maybe it is time to think the unthinkable - that if equity investors are no longer willing to support medical research, someone else must instead. Andrew Lo, a finance professor at the Massachusetts Institute of Technology, says it could be debt investors through CDOs - collateralised drug obligations."